Andrea Bisso

Dr. Andrea Bisso

orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 September 2006 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
DBDaniele Bergamaschi
Daniele Bergamaschi
YSYardena Samuels
Yardena Samuels
ASAlexandra Sullivan
Alexandra Sullivan
MZMarketa Zvelebil
Marketa Zvelebil
HBHilde Breyssens
Hilde Breyssens
XLXin Lu
Xin Lu

16 August 2011 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
RMRoberto Marcucci
Roberto Marcucci
JBJames Brindle
James Brindle
SPSimona Paro
Simona Paro
ACAngela Casadio
Angela Casadio
SHSophie Hempel
Sophie Hempel
MOMary O'connell
Mary O'connell
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.

1 June 2013 in Cell Cycle
Verified
Journal Article
Open access
ABAndrea Bisso
Andrea Bisso
MFMICHELA FALESCHINI
MICHELA FALESCHINI
FZFederico Zampa
Federico Zampa
VCValeria Capaci
Valeria Capaci
JSJacopo De Santa
Jacopo De Santa
GSGiannino Del Sal
Giannino Del Sal
Breast cancer is a heterogeneous tumor type characterized by a complex spectrum of molecular aberrations, resulting in a diverse array of malignant features and clinical outcomes. Deciphering the m...

7 August 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
VCValeria Capaci
Valeria Capaci
LBLorenzo Bascetta
Lorenzo Bascetta
Marco FantuzMarco Fantuz
Marco Fantuz
GBGalina V. Beznoussenko
Galina V. Beznoussenko
RSRoberta Sommaggio
Roberta Sommaggio
GSGiannino Del Sal
Giannino Del Sal
TP53 missense mutations leading to the expression of mutant p53 oncoproteins are frequent driver events during tumorigenesis. p53 mutants promote tumor growth, metastasis and chemoresistance by affecting fundamental cellular pathways and functions. Here, we demonstrate that p53 mutants modify structure and function of the Golgi apparatus, culminating in the increased release of a pro-malignant secretome by tumor cells and primary fibroblasts from patients with Li-Fraumeni cancer predisposition syndrome. Mechanistically, interacting with the hypoxia responsive factor HIF1α, mutant p53 induces the expression of miR-30d, which in turn causes tubulo-vesiculation of the Golgi apparatus, leading to enhanced vesicular trafficking and secretion. The mut-p53/HIF1α/miR-30d axis potentiates the release of soluble factors and the deposition and remodeling of the ECM, affecting mechano-signaling and stromal cells activation within the tumor microenvironment, thereby enhancing tumor growth and metastatic colonization.

22 January 2020 in Hepatology
Verified
Journal Article
Closed access
PDF file
ABAndrea Bisso
Andrea Bisso
MFMarco Filipuzzi
Marco Filipuzzi
GFGianni Paolo Gamarra Figueroa
Gianni Paolo Gamarra Figueroa
GBGiulia Brumana
Giulia Brumana
FBFrancesca Biagioni
Francesca Biagioni
BABruno Amati
Bruno Amati

15 March 2019 in Immunological Reviews
Verified
Journal Article
Closed access
PDF file
ABAndrea Bisso
Andrea Bisso
ASArianna Sabò
Arianna Sabò
BABruno Amati
Bruno Amati